Navigation Links
Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
Date:11/28/2012

tuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer: results from a Phase II, multicenter, single-arm study

Poster SessionEribulin Mesylate

Abstract No:

P1-13-11Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a Phase II, single-arm feasibility study Poster SessionEribulin Mesylate

Abstract No.

P6-11-14Post-hoc safety and tolerability assessment in patients receiving palliative radiation during treatment with eribulin mesylate for metastatic breast cancer

Poster SessionN/A

Abstract No:

P6-09-06Family Members' Burden in Patients with Metastatic and Early Stage Breast Cancer

Poster SessionThe information discussed in this release is about investigational uses for an FDA-approved product. It is not intended to convey conclusions of efficacy and safety.

About Halaven
Halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane either in the adjuvant or metastatic setting. 

Important Safety Information about HalavenDecreased White Blood Cells (Neutropenia)
A doctor should do a blood test to monitor a patient's blood cells before they receive each dose of Halaven, and should monitor them more often if they develop lower white blood cells. If a patient develops severe neutropenia lasting longer than 7 days or neutropenia with a fever, their next dose of Halaven should be delayed and reduced. Severe neutropenia occurred in 57% (287/503) of patients who received Halaven and lasted more than 1 week in 12% (62/503) of patients. Neutropenia with a fever occurred in 5% (23/503) of patients; 2 patients died from compl
'/>"/>

SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
2. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
3. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
4. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
5. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
6. More Practices Join RainTree Oncology Network As Company Expands Presence In Community Oncology
7. The Oncology Nurse Community To Host Live Webinar On Cancer Pain Management
8. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
9. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
10. United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
11. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  Today DePuy Synthes Companies of ... plating systems featuring its proprietary variable angle locking ... trajectory to match patient anatomy and fracture pattern ... The systems are being introduced in conjunction with ... and the International Federation of Foot & Ankle ...
(Date:9/19/2014)... 2014 The Parenteral Drug Association (PDA) is ... changes protocols. The new initiative stems ... by industry participants and regulatory authority representatives at the ... Washington, DC . Representatives of both ... the workshop. Attendees indicated openness to engaging regulators and ...
(Date:9/19/2014)... , Sept. 19, 2014 Today, iHealth Lab ... from Xiaomi Ventures, Ltd. for its first institutional round ... continue expanding iHealth,s global reach, accelerate growth and innovation, ... part of the investment, Xiaomi Ventures will join iHealth,s ... of cloud infrastructure and ecommerce. "We are ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
... Feb. 1 Obese teenagers who,succeeded in losing weight ... their bone mineral content increase over that,period, say researchers ... because adolescence is a critical period for bone,health in ... of the journal Obesity studied 62,adolescents between the ages ...
... as part of innovative,Therapeutics Development Initiative, NEW YORK, ... do whatever it takes to speed delivery of transformative,treatments ... Fox,Foundation for Parkinson,s Research has awarded up to $3 ... push potential new PD treatments,closer to the clinic. The ...
Cached Medicine Technology:Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss 2Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss 3Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development 2Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development 3
(Date:9/21/2014)... (PRWEB) September 21, 2014 Hundreds ... move forward in Pennsylvania’s Philadelphia Court of Common ... documents, the proceeding’s next monthly meeting has been ... number 100300296) , “Our Firm is representing a ... in this litigation. We are pleased with its ...
(Date:9/21/2014)... Dallas, Texas (PRWEB) September 21, 2014 ... Administration (FDA) in 1996, GSK’s Flovent (fluticasone propionate) ... activity. It is used for the maintenance treatment ... is now available in two formulations, Diskus and ... and 2004, respectively. Flovent’s active ingredient, fluticasone propionate, ...
(Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
(Date:9/21/2014)... 2014 C8 lawsuits move forward in ... the list of 20 possible C8 lawsuits selected ... six, reports Wright & Schulte LLC. Court records show ... 2500 C8 lawsuits filed that represent individuals who purportedly ... a result of being exposed to water contaminated by ...
(Date:9/20/2014)... Diabetes Protocol , a breakthrough new ... thousands of people learn how to naturally manage and ... prescriptions has caught the attention of Shane Michaels, prompting ... of millions of people in the U.S. today who ... and unfortunately, big pharma makes a killing just by ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2
... Recovery for Many Facing Health CrisesCHICAGO, Jan. 15 Does ... challenges have found support and compassion through online communities such ... love is more than a dozen roses or candlelit dinner ... and defying the odds for survival. Just ask Lisa, ...
... information on its revamped website. AccessRx has provided tens of ... 1998. , ... (PRWEB) January 15, ... consumer information on its revamped website. AccessRx has provided tens ...
... Two radon-induced lung cancer survivors will be joined by ... Council Radon Awards Ceremony at the National Press ... the U.S. EPA, the ceremony is part of National ... and winners of the National Radon Poster Contest; but ...
... & Nephew,s Advanced Wound Management division (LSE: SN; NYSE: ... Court in the High Court of Justice of England and ... a temporary injunction prohibiting Smith & Nephew from commercializing foam ... Kingdom. The temporary injunction will remain in place until the ...
... Nationally; Many People May Not Realize They,re InfectedHARRISBURG, Pa., ... in the number of reported cases of gonorrhea and ... testing by men and women, according to the Department ... common bacterial sexually transmitted diseases is below the national ...
... with CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will be ... 3rd at 11:30 am Eastern Time. , , Event: ... Dan Starck, President and CEO, ... Date: 11:30 am Eastern Time, Tuesday, ...
Cached Medicine News:Health News:More than Just a Box of Chocolates 2Health News:More than Just a Box of Chocolates 3Health News:AccessRx.com Launches Redesigned Website, Adds Content and Builds Online Community 2Health News:Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure' 2Health News:Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure' 3Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 2Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 3Health News:CorVel Corporation Announces Earnings Release Webcast 2
... Eliminate the need for makeshift, modified nebulizer ... waste time gathering parts when your patient ... to deliver the utmost in Heliox rescue ... is fast becoming the standard of care ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... Entrainment Nebulizers deliver particulate humidity in the ... chronic secretion patients. For your convenience, Thera-Mist® ... supply of sterile water., ,The P30000N, ... of 20-50% with a total flow range ...
... For use with metered dose inhalers., ... aerosolized medication from MDI canisters. Its versatile ... a ventilator circuit, in conjunction with an ... routine, oral inhalation. ACE may also be ...
Medicine Products: